Results 1 - 10 of 1239

< 1 2 3 ... 123 124 >

• Discovery of (S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): a novel, CNS penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM).

  [DOI: 10.1021/jm501375c]
  
• Carr DB; McDonnell Moorehead T; Bouchard A; Sprenger CR; Hamilton DA; Lang E; Madden D; Lacouture PG; Wright C 4th. Effects of injectable HP?CD-diclofenac on the human delayed rectifier potassium channel current in vitro and on proarrhythmic QTc in vivo., Clinical therapeutics

  [PubMed: 23578606]
  [DOI: 10.1016/j.clinthera.2013.03.01]
  
• Darp? B; Sager P; MacConell L; Cirincione B; Mitchell M; Han J; Huang W; Malloy J; Schulteis C; Shen L; Porter L. Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QTc interval in healthy subjects., British journal of clinical pharmacology

  [PubMed: 22882281]
  [DOI: 10.1111/j.1365-2125.2012.04416]
  
• Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece., Clinical therapeutics

  [PubMed: 22818870]
  [DOI: 10.1016/j.clinthera.2012.07.00]
  
• Bray GA; Ryan DH. Drug treatment of obesity., The Psychiatric clinics of North America

  [PubMed: 22098810]
  [DOI: 10.1016/j.psc.2011.08.013]
  
• Barakat GM; Moustafa ME; Bikhazi AB. Effects of selenium and exendin-4 on glucagon-like peptide-1 receptor, IRS-1, and Raf-1 in the liver of diabetic rats., Biochemical genetics

  [PubMed: 22983684]
  [DOI: 10.1007/s10528-012-9532-2]
  
• Ray KK; Ginsberg HN; Davidson MH; Pordy R; Bessac L; Minini P; Eckel RH; Cannon CP. Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control., Circulation

  [PubMed: 27777279]
  [DOI: 10.1161/CIRCULATIONAHA.116.024]
  
• Marquard J; Otter S; Welters A; Piemonti L; K?hler M; Ferrer J; Thorens B; Schliess F; Rupnik MS; Heise T; Berggren PO; Kl?cker N; Meissner T; Stirban A; Mayatepek E; Eberhard D; Kragl M; Lammert E; Fischer A; Eglinger J; Herebian D; Kletke O; Klemen MS; Sto?er A; Wnendt S. Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment., Nature medicine

  [PubMed: 25774850]
  [DOI: 10.1038/nm.3822]
  
• Ansoleaga B; Jov? M; Schl?ter A; Garcia-Esparcia P; Moreno J; Pujol A; Pamplona R; Portero-Ot?n M; Ferrer I. Deregulation of purine metabolism in Alzheimer's disease., Neurobiology of aging

  [PubMed: 25311278]
  [DOI: 10.1016/j.neurobiolaging.2014.]
  
• Wang Y; Tang C; Cheng S; Cui G; Zhang R; Zhang Z; Xie L; Lin Y; Hao W. [A randomized, double-blind, controlled study: Ji-Tai tablet for the treatment of acute withdrawl syndrome of mild heroin dependence]., Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

  [DOI: 10.11817/j.issn.1672-7347.2015]